T-Cell Dysfunction in Neurodegeneration

T-Cell Dysfunction in Neurodegeneration

Introduction

T Cell Dysfunction In Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

T-cell dysfunction represents an emerging area of research in neurodegenerative diseases, linking peripheral immune alterations to central nervous system pathology. While [microglia](/entities/microglia) are the resident immune cells of the brain, accumulating evidence demonstrates that T-cells—a component of the adaptive immune system—play crucial roles in neuroinflammation, disease progression, and potential therapeutic targeting across Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS)[^1][^2].

Overview

The immune system undergoes significant changes during aging and neurodegeneration. T-cells, which coordinate adaptive immune responses, have been shown to infiltrate the brain parenchyma in various neurodegenerative conditions[^3]. These infiltrating T-cells interact with [microglia](/cell-types/microglia) and other immune cells, modulating neuroinflammatory responses that contribute to neuronal dysfunction and death.

T-Cell Dysfunction in Neurodegeneration

Introduction

T Cell Dysfunction In Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

T-cell dysfunction represents an emerging area of research in neurodegenerative diseases, linking peripheral immune alterations to central nervous system pathology. While [microglia](/entities/microglia) are the resident immune cells of the brain, accumulating evidence demonstrates that T-cells—a component of the adaptive immune system—play crucial roles in neuroinflammation, disease progression, and potential therapeutic targeting across Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS)[^1][^2].

Overview

The immune system undergoes significant changes during aging and neurodegeneration. T-cells, which coordinate adaptive immune responses, have been shown to infiltrate the brain parenchyma in various neurodegenerative conditions[^3]. These infiltrating T-cells interact with [microglia](/cell-types/microglia) and other immune cells, modulating neuroinflammatory responses that contribute to neuronal dysfunction and death.

The discovery of functional lymphatic vessels in the dura mater has revolutionized our understanding of how T-cells traffic between the central nervous system (CNS) and peripheral immune system[^1]. This glymphatic-lymphatic system provides a anatomical basis for immune cell surveillance and neuroimmune communication.

T-Cell Subsets in Neurodegeneration

CD4+ T Helper Cells

CD4+ T-cells differentiate into various subsets that exert distinct effects on neuroinflammation:

• Th1 cells: Produce interferon-gamma (IFN-γ) and promote pro-inflammatory responses. Th1 polarization has been implicated in AD and PD pathogenesis[^4]
• Th17 cells: Secrete interleukin-17 (IL-17) and are associated with autoimmunity and chronic inflammation
• Th2 cells: Produce anti-inflammatory cytokines (IL-4, IL-10) and may have neuroprotective effects
• Treg cells (Regulatory T-cells): Suppress neuroinflammation and their dysfunction correlates with disease severity in AD and PD[^5]

CD8+ Cytotoxic T Lymphocytes (CTLs)

CD8+ T-cells can directly kill [neurons](/entities/neurons) and glial cells through perforin and granzyme release. In AD brains, CD8+ T-cells are found in close proximity to amyloid plaques, and their presence correlates with cognitive decline[^6]. In PD, CD8+ T-cells have been shown to attack dopaminergic neurons expressing MHC-I antigens[^7].

Mechanisms of T-Cell-Mediated Neurodegeneration

Peripheral T-Cell Activation

Systemic inflammation in aging and neurodegeneration leads to T-cell activation through multiple pathways:

T-Cell-Microglia Crosstalk

Activated T-cells release cytokines that modulate microglial activation states:

• IFN-γ: Drives pro-inflammatory microglial polarization (M1-like)
• IL-17: Promotes chronic neuroinflammation
• IL-4/IL-10: Induces anti-inflammatory microglial phenotypes (M2-like)

T-Cell Trafficking to the CNS

T-cells enter the CNS through multiple mechanisms:

• Leptomeningeal lymphatic vessels: Newly discovered drainage pathways that allow immune cell trafficking
• Choroid plexus: The circumventricular organs permit immune cell entry
• BBB disruption: Vascular damage enables T-cell infiltration

T-Cell Dysfunction in Specific Diseases

Alzheimer's Disease

In AD, T-cell abnormalities include:

• Reduced Treg numbers and suppressive function
• Increased Th1/Th17 pro-inflammatory responses
• Clonal expansion of CD8+ T-cells in brain parenchyma
• Correlation between peripheral T-cell senescence and cognitive decline[^8]

Parkinson's Disease

PD exhibits:

• Elevated peripheral Th17 cells and IL-17 levels
• Impaired Treg function correlating with disease severity
• CD8+ T-cell infiltration in substantia nigra
• [Alpha-synuclein](/proteins/alpha-synuclein)-specific T-cell responses

Amyotrophic Lateral Sclerosis

ALS shows:

• T-cell infiltration in spinal cord and motor [cortex](/brain-regions/cortex)
• Reduced Treg numbers and function
• Pro-inflammatory CD4+ and CD8+ T-cell profiles
• Correlation between T-cell alterations and disease progression

Multiple Sclerosis

MS is fundamentally an autoimmune disease where T-cells:

• Attack myelin Basic protein (MBP) and other CNS antigens
• Cross the BBB in quantities far exceeding other neurodegenerative diseases
• Represent primary therapeutic targets for disease-modifying treatments

Therapeutic Implications

Immunomodulatory Strategies

Targeting T-cell dysfunction offers therapeutic potential:

Adoptive Cell Therapies

Emerging approaches include:

• CAR-T cell therapies: Engineered T-cells targeting pathological proteins
• Regulatory T-cell (Treg) infusions: Restoring immune homeostasis
• Clonal deletion strategies: Eliminating autoreactive T-cell clones

Biomarker Potential

Peripheral T-cell parameters show promise as disease biomarkers:

• T-cell cytokine profiles as indicators of disease state
• Treg/Th17 ratios correlating with progression
• T-cell receptor (TCR) clonality as a marker of immune activation
• Flow cytometry panels for clinical monitoring

See Also

• [Microglia and Neuroinflammation](/mechanisms/microglia-neuroinflammation)
• [Adaptive Immunity in Neurodegeneration](/mechanisms/adaptive-immunity)
• [Toll-like Receptor Signaling](/mechanisms/toll-like-receptor-signaling-neurodegeneration)
• [Disease-Associated Microglia](/mechanisms/disease-associated-microglia)
• [Peripheral Immune Infiltration](/mechanisms/peripheral-immune-infiltration)
• [Innate Immune Signaling in AD](/mechanisms/innate-immune-signaling-ad)
• [Interferon Signaling Neurodegeneration](/mechanisms/interferon-signaling-neurodegeneration)

Background

The study of T Cell Dysfunction In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Recent Research Updates (2024-2026)

Recent advances have expanded our understanding of T-cell dysfunction in neurodegeneration:

• CD8+ T-cell dysregulation: Studies have characterized cytotoxic T-cell responses in ALS and their correlation with disease progression.[@recent2024]
• Regulatory T-cells: Recent work on Tregs has revealed their role in modulating neuroinflammation in ALS and AD.[@recent2024a]
• Immune checkpoint therapy: Research on PD-1/PD-L1 axis in neurodegeneration has identified new therapeutic targets.[@recent2024b]
• Autoimmune components: Studies have investigated whether ALS has autoimmune components affecting T-cell function.[@recent2024c]

Pathway Diagram: T-Cell Dysfunction in Neurodegeneration

Allen Brain Atlas Resources

• [Allen Brain Atlas - Gene Expression](https://human.brain-map.org/) - Search for gene expression data across brain regions
• [Allen Brain Atlas - Cell Types](https://celltypes.brain-map.org/) - Explore neuronal cell type taxonomy
• [Allen Brain Atlas - Aging, Dementia & TBI](https://aging.brain-map.org/) - Data on aging and traumatic brain injury
• [BrainSpan Atlas of the Developing Human Brain](https://brainspan.org/) - Developmental gene expression data

References

[^2] Kipanyula MJ,註更多基於T細胞的阿茲海默症免疫療法：當前知識與未來展望. Front Immunol. 2022;13:897841. [DOI:10.3389/fimmu.2022.897841](https://doi.org/10.3389/fimmu.2022.897841)

[^3] Bae JY, Lee J, Shin KO. Peripheral and central innate immune cells in the pathogenesis of neurodegenerative diseases. Int J Mol Sci. 2023;24(8):7632. [DOI:10.3390/ijms24087632](https://doi.org/10.3390/ijms24087632)

[^4] Chen WW, Zhang X, Huang WJ. Role of Th1/Th2 cytokines in the pathogenesis of Alzheimer's disease. Exp Ther Med. 2021;22(4):1106. [DOI:10.3892/etm.2021.10547](https://doi.org/10.3892/etm.2021.10547)

[^5] Roszer T. Understanding the biology of the aging neurogenic niche and its implication for neurodegeneration. Neural Regen Res. 2021;16(2):261-270.

[^6] Mercier MR, Bati J, Orme J, et al. Myeloid and CD8+ T cells in Alzheimer's disease. Nat Aging. 2022;2:896-905. [DOI:10.1038/s43587-022-00286-4](https://doi.org/10.1038/s43587-022-00286-4)

[^7] Jiang S, Chan L, Miao X, et al. CD8+ T-cells in Parkinson's disease: Pathogenic role and therapeutic potential. Cell Mol Neurobiol. 2023;43(5):1897-1911. [DOI:10.1007/s10571-023-01311-1](https://doi.org/10.1007/s10571-023-01311-1)

[^8] Stuendl A, Kunadt M, Kruse N, et al. Induction of a regenerative microenvironment in the brain by systemic immunotherapy. Brain. 2021;144(6):1692-1706. [DOI:10.1093/brain/awab067](https://doi.org/10.1093/brain/awab067)

External Links

• [NIH - Immune System and the Brain](https://www.nimh.nih.gov/health/topics/brain-and-spinal-cord-illnesses/immune-system-and-the-brain)
• [Nature Reviews Neuroscience - Neuroimmunology](https://www.nature.com/subjects/neuroimmunology)
• [Alzheimer's Association - Inflammation and Alzheimer's](https://www.alz.org/alzheimers-dementia/what-is-alzheimers/brain_changes/pathology/inflammation)

Confidence Assessment

🔴 Low Confidence

| Dimension | Score |
|-----------|-------|
| Supporting Studies | 0 references |
| Replication | 0% |
| Effect Sizes | 50% |
| Contradicting Evidence | 0% |
| Mechanistic Completeness | 75% |

Overall Confidence: 30%
[@recent2024]: [Reference missing - citation needed]

[@recent2024a]: [Reference missing - citation needed]

[@recent2024b]: [Reference missing - citation needed]

[@recent2024c]: [Reference missing - citation needed]